| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $67.78B | $57.22B | $50.49B | $49.03B | $42.69B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | $54.56B | $62.92B | $50.73B | $13.68B | $5.45B |
| Tax Expense | $3.41B | $2.69B | $3.17B | $3.99B | $3.62B |
| Net Income | $20.54B | $8.84B | $10.78B | $17.43B | $14.30B |
| EPS (basic) | 11.5700 | 4.7300 | 5.6100 | 9.4800 | 7.7300 |
| EPS (diluted) | 11.5600 | 4.7200 | 5.6000 | 9.4700 | 7.7200 |
| Shares (diluted) | $1.73B | $1.76B | $1.82B | $1.81B | $1.82B |